Evidence map›Paper›PMID 28903536›Full record

ArticleGenome biology and evolution2017

An Alternative Strategy for Trypanosome Survival in the Mammalian Bloodstream Revealed through Genome and Transcriptome Analysis of the Ubiquitous Bovine Parasite Trypanosoma (Megatrypanum) theileri.

Steven Kelly, Alasdair Ivens, G Adam Mott, Ellis O'Neill, David Emms, Olivia Macleod, Paul Voorheis, Kevin Tyler, Matthew Clark, Jacqueline Matthews and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology and evolution, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The ElusivePathogens (Basel, Switzerland) · 2023
    Review
  7. Molecular identification ofFrontiers in veterinary science · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Steven KellyDepartment of Plant Sciences, University of Oxford, United Kingdom.
Alasdair IvensCentre for Immunity, Infection and Evolution and Institute for Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, United Kingdom.
G Adam MottCentre for Immunity, Infection and Evolution and Institute for Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, United Kingdom.
Ellis O'NeillDepartment of Plant Sciences, University of Oxford, United Kingdom.
David EmmsDepartment of Plant Sciences, University of Oxford, United Kingdom.
Olivia MacleodDepartment of Biochemistry, University of Cambridge, United Kingdom.
Paul VoorheisSchool of Biochemistry and Immunology, Trinity College, Dublin, Ireland.
Kevin TylerNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, Norfolk, United Kingdom.
Matthew ClarkEarlham Institute, Norwich Research Park, Norwich, Norfolk, United Kingdom.
Jacqueline MatthewsMoredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik, Midlothian, United Kingdom.
Keith MatthewsCentre for Immunity, Infection and Evolution and Institute for Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, United Kingdom.
Mark CarringtonDepartment of Biochemistry, University of Cambridge, United Kingdom.
Centre for Immunity, Infection and Evolution · GBUniversity of Oxford · GBUniversity of Cambridge · GBMoredun Research Institute · GBNorwich Research Park · GBTrinity College Dublin · IEUniversity of East Anglia · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F00057X/1Wellcome Trust 103740/Z/14/Z
6 · The paper itself

Abstract

There are hundreds of Trypanosoma species that live in the blood and tissue spaces of their vertebrate hosts. The vast majority of these do not have the ornate system of antigenic variation that has evolved in the small number of African trypanosome species, but can still maintain long-term infections in the face of the vertebrate adaptive immune system. Trypanosoma theileri is a typical example, has a restricted host range of cattle and other Bovinae, and is only occasionally reported to cause patent disease although no systematic survey of the effect of infection on agricultural productivity has been performed. Here, a detailed genome sequence and a transcriptome analysis of gene expression in bloodstream form T. theileri have been performed. Analysis of the genome sequence and expression showed that T. theileri has a typical kinetoplastid genome structure and allowed a prediction that it is capable of meiotic exchange, gene silencing via RNA interference and, potentially, density-dependent growth control. In particular, the transcriptome analysis has allowed a comparison of two distinct trypanosome cell surfaces, T. brucei and T. theileri, that have each evolved to enable the maintenance of a long-term extracellular infection in cattle. The T. theileri cell surface can be modeled to contain a mixture of proteins encoded by four novel large and divergent gene families and by members of a major surface protease gene family. This surface composition is distinct from the uniform variant surface glycoprotein coat on African trypanosomes providing an insight into a second mechanism used by trypanosome species that proliferate in an extracellular milieu in vertebrate hosts to avoid the adaptive immune response.

Indexed as

AnimalsBloodCattleCell CycleGene Expression ProfilingGene SilencingGenome, ProtozoanHost-Parasite InteractionsPhylogenyProtozoan ProteinsRNA InterferenceRNA, MessengerSucroseTrypanosomaTrypanosomiasis, BovineProtozoan ProteinsRNA, MessengerSucrosecell surface componentsgenometranscriptomeTrypanosoma theileri

Identifiers

PMID28903536
PMCPMC5737535
OpenAlexW2750200474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.